As it pre­pares to join EQT, Life Sci­ence Part­ners sur­pass­es €1B in­vest­ment mark

Just a few months ago, the Eu­ro­pean in­vest­ment firm Life Sci­ence Part­ners an­nounced that it would be bought out by the pri­vate in­vest­ment group EQT. Fri­day, it re­vealed that it has sur­passed the €1 bil­lion fundrais­ing mark for its flag­ship fund LSP 7, a feat that it says makes it the largest life sci­ences VC raise in Eu­rope.

LSP in­vests in drug de­vel­op­ment and medtech com­pa­nies in Eu­rope, specif­i­cal­ly fo­cus­ing on spin­outs from uni­ver­si­ties that have large port­fo­lios. The goal is to in­vest in about 15 or 20 com­pa­nies, both in large in­di­ca­tions and rare dis­eases, to help ad­vance the life sci­ences in­dus­try in Eu­rope.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER